

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.20684002 |
| 2 | NIK/NF-kappaB signaling (GO:0038061) | 5.34028236 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.83359698 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.83359698 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.79205897 |
| 6 | negative regulation of interleukin-12 production (GO:0032695) | 4.77814318 |
| 7 | positive regulation of B cell differentiation (GO:0045579) | 4.25084000 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.22296488 |
| 9 | myeloid dendritic cell activation (GO:0001773) | 4.16304638 |
| 10 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.11220492 |
| 11 | defense response to protozoan (GO:0042832) | 4.09632454 |
| 12 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.09101994 |
| 13 | myeloid dendritic cell differentiation (GO:0043011) | 4.07509075 |
| 14 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.00129018 |
| 15 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.92762465 |
| 16 | neutrophil activation involved in immune response (GO:0002283) | 3.90003114 |
| 17 | negative regulation of cell killing (GO:0031342) | 3.89024825 |
| 18 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.89024825 |
| 19 | regulation of RIG-I signaling pathway (GO:0039535) | 3.86626003 |
| 20 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.85236539 |
| 21 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.81960079 |
| 22 | regulation of chronic inflammatory response (GO:0002676) | 3.79621880 |
| 23 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.77964987 |
| 24 | response to interferon-beta (GO:0035456) | 3.76599675 |
| 25 | regulation of T cell tolerance induction (GO:0002664) | 3.75977918 |
| 26 | immunoglobulin mediated immune response (GO:0016064) | 3.73993569 |
| 27 | response to protozoan (GO:0001562) | 3.73152558 |
| 28 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.72491941 |
| 29 | regulation of B cell differentiation (GO:0045577) | 3.70621498 |
| 30 | ribosomal small subunit assembly (GO:0000028) | 3.70205607 |
| 31 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.68897901 |
| 32 | T-helper 1 type immune response (GO:0042088) | 3.64898479 |
| 33 | response to muramyl dipeptide (GO:0032495) | 3.61621239 |
| 34 | positive regulation by symbiont of host defense response (GO:0052509) | 3.60369517 |
| 35 | modulation by symbiont of host defense response (GO:0052031) | 3.60369517 |
| 36 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.60369517 |
| 37 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.60369517 |
| 38 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.60369517 |
| 39 | modulation by symbiont of host immune response (GO:0052553) | 3.60369517 |
| 40 | type I interferon signaling pathway (GO:0060337) | 3.55582799 |
| 41 | cellular response to type I interferon (GO:0071357) | 3.55582799 |
| 42 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.54934030 |
| 43 | dendritic cell differentiation (GO:0097028) | 3.54880582 |
| 44 | negative thymic T cell selection (GO:0045060) | 3.53683457 |
| 45 | response to type I interferon (GO:0034340) | 3.51475043 |
| 46 | response to interleukin-15 (GO:0070672) | 3.50753388 |
| 47 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.50438071 |
| 48 | macrophage activation involved in immune response (GO:0002281) | 3.46966924 |
| 49 | regulation of tolerance induction (GO:0002643) | 3.46677514 |
| 50 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.44765938 |
| 51 | cellular response to interleukin-15 (GO:0071350) | 3.41062598 |
| 52 | mature B cell differentiation (GO:0002335) | 3.40679248 |
| 53 | cellular response to interferon-beta (GO:0035458) | 3.40520214 |
| 54 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.39640013 |
| 55 | positive regulation of antigen processing and presentation (GO:0002579) | 3.39075813 |
| 56 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.37725073 |
| 57 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.37455089 |
| 58 | regulation of necroptotic process (GO:0060544) | 3.37098348 |
| 59 | B cell mediated immunity (GO:0019724) | 3.36775003 |
| 60 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.34887196 |
| 61 | neutrophil activation (GO:0042119) | 3.34457223 |
| 62 | regulation of activation of Janus kinase activity (GO:0010533) | 3.31508400 |
| 63 | negative regulation of T cell mediated immunity (GO:0002710) | 3.31433994 |
| 64 | negative T cell selection (GO:0043383) | 3.30234498 |
| 65 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.28993498 |
| 66 | regulation of T-helper cell differentiation (GO:0045622) | 3.28504718 |
| 67 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.27737580 |
| 68 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.26102897 |
| 69 | mature B cell differentiation involved in immune response (GO:0002313) | 3.26067474 |
| 70 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.25510480 |
| 71 | regulation of hypersensitivity (GO:0002883) | 3.24985092 |
| 72 | response to peptidoglycan (GO:0032494) | 3.24215956 |
| 73 | positive regulation of interleukin-12 production (GO:0032735) | 3.23783550 |
| 74 | leukocyte aggregation (GO:0070486) | 3.22235842 |
| 75 | positive regulation of interleukin-2 production (GO:0032743) | 3.21999582 |
| 76 | tolerance induction (GO:0002507) | 3.21938271 |
| 77 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.20305527 |
| 78 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.20288547 |
| 79 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.19176718 |
| 80 | negative regulation of interleukin-17 production (GO:0032700) | 3.18695663 |
| 81 | necroptotic process (GO:0070266) | 3.18418773 |
| 82 | granulocyte activation (GO:0036230) | 3.18389890 |
| 83 | cellular extravasation (GO:0045123) | 3.18370732 |
| 84 | positive regulation of interleukin-10 production (GO:0032733) | 3.16550172 |
| 85 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.15119952 |
| 86 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.15119952 |
| 87 | T-helper cell differentiation (GO:0042093) | 3.12366191 |
| 88 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.12366191 |
| 89 | regulation of vitamin metabolic process (GO:0030656) | 3.11618590 |
| 90 | germinal center formation (GO:0002467) | 3.10672977 |
| 91 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.10299471 |
| 92 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.09322781 |
| 93 | positive regulation of type 2 immune response (GO:0002830) | 3.08778322 |
| 94 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.07981369 |
| 95 | natural killer cell mediated immunity (GO:0002228) | 3.07981369 |
| 96 | detection of molecule of bacterial origin (GO:0032490) | 3.07649092 |
| 97 | regulation of antigen processing and presentation (GO:0002577) | 3.07327052 |
| 98 | detection of other organism (GO:0098543) | 3.06915564 |
| 99 | positive regulation of tolerance induction (GO:0002645) | 3.06700935 |
| 100 | regulation of natural killer cell differentiation (GO:0032823) | 3.05917176 |
| 101 | regulation of regulatory T cell differentiation (GO:0045589) | 3.02867969 |
| 102 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.01817344 |
| 103 | cellular response to zinc ion (GO:0071294) | 3.01445671 |
| 104 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.00761200 |
| 105 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.98863005 |
| 106 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.98832790 |
| 107 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.98832790 |
| 108 | positive regulation of natural killer cell activation (GO:0032816) | 2.97480280 |
| 109 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.97405991 |
| 110 | regulation of interferon-alpha production (GO:0032647) | 2.97094680 |
| 111 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.96150868 |
| 112 | positive regulation of interleukin-17 production (GO:0032740) | 2.95247511 |
| 113 | regulation of interleukin-17 production (GO:0032660) | 2.94965694 |
| 114 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.94644001 |
| 115 | myeloid cell activation involved in immune response (GO:0002275) | 2.93999132 |
| 116 | regulation of memory T cell differentiation (GO:0043380) | 2.93184208 |
| 117 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.92326070 |
| 118 | natural killer cell activation (GO:0030101) | 2.91765437 |
| 119 | cytidine deamination (GO:0009972) | 2.91719206 |
| 120 | cytidine metabolic process (GO:0046087) | 2.91719206 |
| 121 | cytidine catabolic process (GO:0006216) | 2.91719206 |
| 122 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.90516525 |
| 123 | regulation of natural killer cell activation (GO:0032814) | 2.90164110 |
| 124 | interferon-gamma production (GO:0032609) | 2.89535291 |
| 125 | positive regulation of interferon-alpha production (GO:0032727) | 2.89414706 |
| 126 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.86924924 |
| 127 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.85721518 |
| 128 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.85549813 |
| 129 | lymphocyte chemotaxis (GO:0048247) | 2.84748269 |
| 130 | positive regulation of activated T cell proliferation (GO:0042104) | 2.84440464 |
| 131 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.83720476 |
| 132 | regulation of interleukin-12 production (GO:0032655) | 2.82665170 |
| 133 | regulation of T-helper 1 type immune response (GO:0002825) | 2.82560208 |
| 134 | negative regulation of necroptotic process (GO:0060546) | 2.81237218 |
| 135 | T cell migration (GO:0072678) | 2.80993791 |
| 136 | positive regulation of defense response to virus by host (GO:0002230) | 2.79793219 |
| 137 | positive regulation of humoral immune response (GO:0002922) | 2.78865645 |
| 138 | regulation of gamma-delta T cell activation (GO:0046643) | 2.78550476 |
| 139 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.76762675 |
| 140 | response to interferon-alpha (GO:0035455) | 2.75834379 |
| 141 | definitive hemopoiesis (GO:0060216) | 2.75281301 |
| 142 | negative regulation of viral genome replication (GO:0045071) | 2.74762328 |
| 143 | mast cell activation (GO:0045576) | 2.74269494 |
| 144 | T cell homeostasis (GO:0043029) | 2.73931819 |
| 145 | natural killer cell differentiation (GO:0001779) | 2.73586358 |
| 146 | positive regulation of macrophage differentiation (GO:0045651) | 2.73556388 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.78820605 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.75168159 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.62123558 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.40167570 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.78440696 |
| 6 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.72888607 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.65078806 |
| 8 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.56113236 |
| 9 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.33109286 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.26720691 |
| 11 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.24734286 |
| 12 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.95265708 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.93558759 |
| 14 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.91227901 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.90157645 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.79991768 |
| 17 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.76263253 |
| 18 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.64681935 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.58992514 |
| 20 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.55355644 |
| 21 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.49873832 |
| 22 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.49613074 |
| 23 | MYB_26560356_Chip-Seq_TH2_Human | 2.41880784 |
| 24 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.31305753 |
| 25 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.29732802 |
| 26 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.25172726 |
| 27 | GATA1_22025678_ChIP-Seq_K562_Human | 2.22042148 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.17999438 |
| 29 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.16312075 |
| 30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.14684104 |
| 31 | MAF_26560356_Chip-Seq_TH1_Human | 2.12785874 |
| 32 | MYB_26560356_Chip-Seq_TH1_Human | 2.06858169 |
| 33 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.06337571 |
| 34 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.01092469 |
| 35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.93825515 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.89919143 |
| 37 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88066714 |
| 38 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.85880971 |
| 39 | MYC_22102868_ChIP-Seq_BL_Human | 1.83362201 |
| 40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82753141 |
| 41 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.79517601 |
| 42 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74192815 |
| 43 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.73314471 |
| 44 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.70679916 |
| 45 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.66578707 |
| 46 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.58908845 |
| 47 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.53979588 |
| 48 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.47857057 |
| 49 | UTX_26944678_Chip-Seq_JUKART_Human | 1.47690374 |
| 50 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.45663433 |
| 51 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.44388665 |
| 52 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.42685582 |
| 53 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.41938523 |
| 54 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.40865408 |
| 55 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.38907842 |
| 56 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.38276789 |
| 57 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.37667916 |
| 58 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.35140854 |
| 59 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.34485060 |
| 60 | MAF_26560356_Chip-Seq_TH2_Human | 1.33369377 |
| 61 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.32926842 |
| 62 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.31203458 |
| 63 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.30384019 |
| 64 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.29624846 |
| 65 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.28317295 |
| 66 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.25952879 |
| 67 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.19546985 |
| 68 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.18591597 |
| 69 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18248701 |
| 70 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17395931 |
| 71 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.16133138 |
| 72 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.15907170 |
| 73 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.11424315 |
| 74 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08806685 |
| 75 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.08683325 |
| 76 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.05651565 |
| 77 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.04316513 |
| 78 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.03933014 |
| 79 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03643459 |
| 80 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.03279959 |
| 81 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.03012064 |
| 82 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 0.99304824 |
| 83 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99255182 |
| 84 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98458350 |
| 85 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.96823097 |
| 86 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96727318 |
| 87 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96463341 |
| 88 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.93537627 |
| 89 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.92006267 |
| 90 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91933644 |
| 91 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.90159959 |
| 92 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89404010 |
| 93 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.89265666 |
| 94 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.88568320 |
| 95 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88448160 |
| 96 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.86990289 |
| 97 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86084524 |
| 98 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84584706 |
| 99 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.83837296 |
| 100 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.83133629 |
| 101 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.81778839 |
| 102 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.80768704 |
| 103 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.77086664 |
| 104 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.76825035 |
| 105 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.75797470 |
| 106 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.75393521 |
| 107 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.74275334 |
| 108 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.74226720 |
| 109 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.73606232 |
| 110 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.73529280 |
| 111 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.72573583 |
| 112 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71159086 |
| 113 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69775005 |
| 114 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.65646557 |
| 115 | * GATA3_26560356_Chip-Seq_TH1_Human | 0.64055944 |
| 116 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.63864293 |
| 117 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.61894418 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.96267503 |
| 2 | MP0000685_abnormal_immune_system | 3.86307604 |
| 3 | MP0005671_abnormal_response_to | 3.78000257 |
| 4 | MP0009785_altered_susceptibility_to | 3.61422780 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.31887043 |
| 6 | MP0003436_decreased_susceptibility_to | 3.07989211 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.02055343 |
| 8 | MP0001790_abnormal_immune_system | 3.00788102 |
| 9 | MP0005387_immune_system_phenotype | 3.00788102 |
| 10 | * MP0001800_abnormal_humoral_immune | 2.86364426 |
| 11 | MP0002166_altered_tumor_susceptibility | 2.83528128 |
| 12 | MP0005025_abnormal_response_to | 2.74601361 |
| 13 | * MP0002452_abnormal_antigen_presenting | 2.66796938 |
| 14 | * MP0002723_abnormal_immune_serum | 2.66038103 |
| 15 | MP0002396_abnormal_hematopoietic_system | 2.61489060 |
| 16 | MP0001348_abnormal_lacrimal_gland | 2.55816793 |
| 17 | * MP0001819_abnormal_immune_cell | 2.51761518 |
| 18 | * MP0002420_abnormal_adaptive_immunity | 2.50972129 |
| 19 | MP0002419_abnormal_innate_immunity | 2.49565006 |
| 20 | MP0002006_tumorigenesis | 2.46775069 |
| 21 | MP0003763_abnormal_thymus_physiology | 2.41054484 |
| 22 | MP0003724_increased_susceptibility_to | 2.38674647 |
| 23 | MP0004510_myositis | 2.34801239 |
| 24 | MP0001853_heart_inflammation | 2.29000967 |
| 25 | * MP0002398_abnormal_bone_marrow | 2.26418459 |
| 26 | MP0005464_abnormal_platelet_physiology | 2.14204203 |
| 27 | * MP0000716_abnormal_immune_system | 2.08926249 |
| 28 | MP0002138_abnormal_hepatobiliary_system | 2.05961420 |
| 29 | MP0001873_stomach_inflammation | 2.02955188 |
| 30 | MP0001545_abnormal_hematopoietic_system | 2.01237939 |
| 31 | MP0005397_hematopoietic_system_phenotyp | 2.01237939 |
| 32 | MP0005310_abnormal_salivary_gland | 1.99108765 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.90351621 |
| 34 | MP0002405_respiratory_system_inflammati | 1.89339891 |
| 35 | MP0002163_abnormal_gland_morphology | 1.83177182 |
| 36 | MP0006082_CNS_inflammation | 1.81949383 |
| 37 | MP0004808_abnormal_hematopoietic_stem | 1.81192988 |
| 38 | MP0000689_abnormal_spleen_morphology | 1.78127752 |
| 39 | * MP0002429_abnormal_blood_cell | 1.76628316 |
| 40 | MP0002722_abnormal_immune_system | 1.73606701 |
| 41 | MP0003303_peritoneal_inflammation | 1.72561784 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.66701404 |
| 43 | MP0005174_abnormal_tail_pigmentation | 1.65090080 |
| 44 | MP0009333_abnormal_splenocyte_physiolog | 1.63749364 |
| 45 | MP0002009_preneoplasia | 1.55511339 |
| 46 | MP0004947_skin_inflammation | 1.53915428 |
| 47 | MP0005167_abnormal_blood-brain_barrier | 1.41013837 |
| 48 | * MP0008469_abnormal_protein_level | 1.39801634 |
| 49 | MP0000490_abnormal_crypts_of | 1.39198706 |
| 50 | MP0008057_abnormal_DNA_replication | 1.38725383 |
| 51 | MP0000703_abnormal_thymus_morphology | 1.37005462 |
| 52 | MP0005451_abnormal_body_composition | 1.36424502 |
| 53 | MP0003866_abnormal_defecation | 1.34145523 |
| 54 | MP0009840_abnormal_foam_cell | 1.33047895 |
| 55 | MP0001533_abnormal_skeleton_physiology | 1.29352918 |
| 56 | MP0009764_decreased_sensitivity_to | 1.28202287 |
| 57 | MP0005075_abnormal_melanosome_morpholog | 1.27135484 |
| 58 | MP0008004_abnormal_stomach_pH | 1.22994256 |
| 59 | MP0003300_gastrointestinal_ulcer | 1.18143977 |
| 60 | MP0000465_gastrointestinal_hemorrhage | 1.16771810 |
| 61 | MP0002877_abnormal_melanocyte_morpholog | 1.10125428 |
| 62 | MP0008007_abnormal_cellular_replicative | 1.10011704 |
| 63 | MP0002254_reproductive_system_inflammat | 1.09840158 |
| 64 | MP0009278_abnormal_bone_marrow | 1.07762649 |
| 65 | MP0003806_abnormal_nucleotide_metabolis | 1.07321407 |
| 66 | MP0005379_endocrine/exocrine_gland_phen | 1.06254812 |
| 67 | MP0002933_joint_inflammation | 1.05601708 |
| 68 | MP0000858_altered_metastatic_potential | 1.04567742 |
| 69 | MP0003448_altered_tumor_morphology | 1.02876964 |
| 70 | MP0003045_fibrosis | 0.99986676 |
| 71 | MP0002277_abnormal_respiratory_mucosa | 0.99700653 |
| 72 | MP0002095_abnormal_skin_pigmentation | 0.99618692 |
| 73 | MP0000604_amyloidosis | 0.94146915 |
| 74 | MP0001346_abnormal_lacrimal_gland | 0.94077782 |
| 75 | MP0002019_abnormal_tumor_incidence | 0.91290068 |
| 76 | MP0000343_altered_response_to | 0.90865620 |
| 77 | MP0002332_abnormal_exercise_endurance | 0.84592075 |
| 78 | MP0005058_abnormal_lysosome_morphology | 0.81100234 |
| 79 | MP0009763_increased_sensitivity_to | 0.79353144 |
| 80 | MP0005164_abnormal_response_to | 0.78423005 |
| 81 | MP0004381_abnormal_hair_follicle | 0.77324611 |
| 82 | MP0003172_abnormal_lysosome_physiology | 0.77032225 |
| 83 | MP0000015_abnormal_ear_pigmentation | 0.76564501 |
| 84 | MP0003943_abnormal_hepatobiliary_system | 0.76545603 |
| 85 | MP0003453_abnormal_keratinocyte_physiol | 0.75706216 |
| 86 | MP0003191_abnormal_cellular_cholesterol | 0.75590901 |
| 87 | MP0003690_abnormal_glial_cell | 0.74406619 |
| 88 | MP0008058_abnormal_DNA_repair | 0.73546277 |
| 89 | MP0003075_altered_response_to | 0.73106032 |
| 90 | MP0002139_abnormal_hepatobiliary_system | 0.72521698 |
| 91 | MP0000371_diluted_coat_color | 0.72132585 |
| 92 | MP0000569_abnormal_digit_pigmentation | 0.69009006 |
| 93 | MP0010352_gastrointestinal_tract_polyps | 0.68637762 |
| 94 | MP0003183_abnormal_peptide_metabolism | 0.68461124 |
| 95 | MP0001851_eye_inflammation | 0.67644941 |
| 96 | MP0004883_abnormal_blood_vessel | 0.67060732 |
| 97 | MP0000249_abnormal_blood_vessel | 0.66775342 |
| 98 | MP0003195_calcinosis | 0.65839563 |
| 99 | MP0002998_abnormal_bone_remodeling | 0.65233241 |
| 100 | MP0009765_abnormal_xenobiotic_induced | 0.65053313 |
| 101 | MP0003646_muscle_fatigue | 0.63623822 |
| 102 | MP0008260_abnormal_autophagy | 0.63447048 |
| 103 | MP0003828_pulmonary_edema | 0.63306947 |
| 104 | MP0000313_abnormal_cell_death | 0.62908460 |
| 105 | MP0001663_abnormal_digestive_system | 0.62646993 |
| 106 | MP0002693_abnormal_pancreas_physiology | 0.62264310 |
| 107 | MP0004782_abnormal_surfactant_physiolog | 0.60742792 |
| 108 | MP0002132_abnormal_respiratory_system | 0.59900551 |
| 109 | MP0010307_abnormal_tumor_latency | 0.59667889 |
| 110 | MP0003795_abnormal_bone_structure | 0.59539207 |
| 111 | MP0000609_abnormal_liver_physiology | 0.58198624 |
| 112 | MP0003077_abnormal_cell_cycle | 0.56773076 |
| 113 | MP0005535_abnormal_body_temperature | 0.56325331 |
| 114 | MP0005390_skeleton_phenotype | 0.55204541 |
| 115 | MP0010094_abnormal_chromosome_stability | 0.54812746 |
| 116 | MP0003186_abnormal_redox_activity | 0.54375326 |
| 117 | MP0002928_abnormal_bile_duct | 0.53728655 |
| 118 | MP0000920_abnormal_myelination | 0.53300346 |
| 119 | MP0003656_abnormal_erythrocyte_physiolo | 0.53029001 |
| 120 | MP0001986_abnormal_taste_sensitivity | 0.52790163 |
| 121 | MP0003221_abnormal_cardiomyocyte_apopto | 0.52193525 |
| 122 | MP0005084_abnormal_gallbladder_morpholo | 0.51441845 |
| 123 | MP0003693_abnormal_embryo_hatching | 0.47347023 |
| 124 | MP0005166_decreased_susceptibility_to | 0.45901947 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myositis (HP:0100614) | 5.58274644 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.13209525 |
| 3 | Retrobulbar optic neuritis (HP:0100654) | 5.02657267 |
| 4 | Optic neuritis (HP:0100653) | 5.02657267 |
| 5 | Recurrent abscess formation (HP:0002722) | 5.01266308 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 4.81526119 |
| 7 | Orchitis (HP:0100796) | 4.78184266 |
| 8 | Eczematoid dermatitis (HP:0000976) | 4.43822019 |
| 9 | Thrombocytosis (HP:0001894) | 4.31825389 |
| 10 | Chronic otitis media (HP:0000389) | 4.20888065 |
| 11 | Recurrent fungal infections (HP:0002841) | 4.03081691 |
| 12 | Vasculitis (HP:0002633) | 3.88801083 |
| 13 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.84540893 |
| 14 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.81440523 |
| 15 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.81440523 |
| 16 | Abnormality of glycolipid metabolism (HP:0010969) | 3.81440523 |
| 17 | Recurrent viral infections (HP:0004429) | 3.80358012 |
| 18 | Increased IgM level (HP:0003496) | 3.69183613 |
| 19 | IgM deficiency (HP:0002850) | 3.68152806 |
| 20 | Mediastinal lymphadenopathy (HP:0100721) | 3.64882123 |
| 21 | Autoimmune thrombocytopenia (HP:0001973) | 3.57401891 |
| 22 | Abnormality of macrophages (HP:0004311) | 3.46888911 |
| 23 | Recurrent skin infections (HP:0001581) | 3.40799501 |
| 24 | Recurrent bronchitis (HP:0002837) | 3.39487542 |
| 25 | B lymphocytopenia (HP:0010976) | 3.36727546 |
| 26 | Abnormality of B cell number (HP:0010975) | 3.36727546 |
| 27 | Abnormality of T cell physiology (HP:0011840) | 3.33737773 |
| 28 | Meningitis (HP:0001287) | 3.31552761 |
| 29 | Pulmonary infiltrates (HP:0002113) | 3.27955198 |
| 30 | Petechiae (HP:0000967) | 3.20230958 |
| 31 | Keratoconjunctivitis sicca (HP:0001097) | 3.19554805 |
| 32 | Aplastic anemia (HP:0001915) | 3.17682235 |
| 33 | Arterial thrombosis (HP:0004420) | 3.15781895 |
| 34 | Panhypogammaglobulinemia (HP:0003139) | 3.09185270 |
| 35 | Nasal polyposis (HP:0100582) | 3.06423740 |
| 36 | Recurrent cutaneous fungal infections (HP:0011370) | 3.03960096 |
| 37 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.03960096 |
| 38 | Agammaglobulinemia (HP:0004432) | 3.02518195 |
| 39 | Hypergammaglobulinemia (HP:0010702) | 3.02423811 |
| 40 | Hemoptysis (HP:0002105) | 3.02395152 |
| 41 | IgG deficiency (HP:0004315) | 3.00024352 |
| 42 | Abnormality of T cells (HP:0002843) | 2.99048288 |
| 43 | Chronic obstructive pulmonary disease (HP:0006510) | 2.95536501 |
| 44 | Obstructive lung disease (HP:0006536) | 2.95536501 |
| 45 | Keratoconjunctivitis (HP:0001096) | 2.92613720 |
| 46 | Encephalitis (HP:0002383) | 2.92148470 |
| 47 | Fatigue (HP:0012378) | 2.91758911 |
| 48 | Abnormality of the nasal mucosa (HP:0000433) | 2.89784273 |
| 49 | Gastrointestinal infarctions (HP:0005244) | 2.87356555 |
| 50 | Cellulitis (HP:0100658) | 2.78743378 |
| 51 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.76185791 |
| 52 | Spontaneous hematomas (HP:0007420) | 2.76043708 |
| 53 | Acute myeloid leukemia (HP:0004808) | 2.75678693 |
| 54 | Increased IgE level (HP:0003212) | 2.71701724 |
| 55 | Autoimmune hemolytic anemia (HP:0001890) | 2.70814101 |
| 56 | Abnormality of T cell number (HP:0011839) | 2.70322567 |
| 57 | Increased cerebral lipofuscin (HP:0011813) | 2.69934408 |
| 58 | Epistaxis (HP:0000421) | 2.68451565 |
| 59 | Inflammation of the large intestine (HP:0002037) | 2.67622504 |
| 60 | Leukocytosis (HP:0001974) | 2.65729386 |
| 61 | Anorexia (HP:0002039) | 2.64543199 |
| 62 | Chest pain (HP:0100749) | 2.63996555 |
| 63 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.62993106 |
| 64 | Prolonged bleeding time (HP:0003010) | 2.62908113 |
| 65 | Granulocytopenia (HP:0001913) | 2.62673977 |
| 66 | Abnormality of the fingertips (HP:0001211) | 2.60760829 |
| 67 | Gingival bleeding (HP:0000225) | 2.60554853 |
| 68 | Gastrointestinal inflammation (HP:0004386) | 2.59481540 |
| 69 | Polyneuropathy (HP:0001271) | 2.58631412 |
| 70 | Chronic diarrhea (HP:0002028) | 2.58163076 |
| 71 | Abnormality of the prostate (HP:0008775) | 2.57686179 |
| 72 | Eosinophilia (HP:0001880) | 2.57543334 |
| 73 | Abnormality of eosinophils (HP:0001879) | 2.55479683 |
| 74 | Thyroiditis (HP:0100646) | 2.55051139 |
| 75 | Interstitial pulmonary disease (HP:0006530) | 2.54286840 |
| 76 | Gastrointestinal stroma tumor (HP:0100723) | 2.53072107 |
| 77 | Amaurosis fugax (HP:0100576) | 2.52814358 |
| 78 | Systemic lupus erythematosus (HP:0002725) | 2.50026203 |
| 79 | Disinhibition (HP:0000734) | 2.49262481 |
| 80 | Lymphopenia (HP:0001888) | 2.49026230 |
| 81 | Colitis (HP:0002583) | 2.47086725 |
| 82 | Stomatitis (HP:0010280) | 2.46277329 |
| 83 | Increased serum ferritin (HP:0003281) | 2.44473787 |
| 84 | Dysostosis multiplex (HP:0000943) | 2.39283622 |
| 85 | Combined immunodeficiency (HP:0005387) | 2.38904200 |
| 86 | Episodic fever (HP:0001954) | 2.36917428 |
| 87 | IgA deficiency (HP:0002720) | 2.36469188 |
| 88 | Pustule (HP:0200039) | 2.36097011 |
| 89 | Loss of speech (HP:0002371) | 2.34653378 |
| 90 | Neutropenia (HP:0001875) | 2.32377125 |
| 91 | Periodontitis (HP:0000704) | 2.32329104 |
| 92 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.28415133 |
| 93 | Abnormal number of erythroid precursors (HP:0012131) | 2.26538355 |
| 94 | Lymphoma (HP:0002665) | 2.23891791 |
| 95 | Albinism (HP:0001022) | 2.23001193 |
| 96 | Gangrene (HP:0100758) | 2.22487780 |
| 97 | Basal ganglia calcification (HP:0002135) | 2.22354396 |
| 98 | T lymphocytopenia (HP:0005403) | 2.21237182 |
| 99 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.21136159 |
| 100 | Glomerulopathy (HP:0100820) | 2.18768287 |
| 101 | Gingivitis (HP:0000230) | 2.18752673 |
| 102 | Keratitis (HP:0000491) | 2.17769701 |
| 103 | Urticaria (HP:0001025) | 2.16197403 |
| 104 | Severe combined immunodeficiency (HP:0004430) | 2.15768437 |
| 105 | Vertigo (HP:0002321) | 2.15090737 |
| 106 | Hypertensive crisis (HP:0100735) | 2.13324488 |
| 107 | Pulmonary embolism (HP:0002204) | 2.13259402 |
| 108 | Reticulocytopenia (HP:0001896) | 2.13210432 |
| 109 | Arthralgia (HP:0002829) | 2.11378371 |
| 110 | Recurrent pneumonia (HP:0006532) | 2.11182788 |
| 111 | Exertional dyspnea (HP:0002875) | 2.10111145 |
| 112 | Abnormality of the pleura (HP:0002103) | 2.09404539 |
| 113 | Abnormal platelet function (HP:0011869) | 2.09224306 |
| 114 | Impaired platelet aggregation (HP:0003540) | 2.09224306 |
| 115 | Hematochezia (HP:0002573) | 2.08331762 |
| 116 | Osteomyelitis (HP:0002754) | 2.05732602 |
| 117 | Vacuolated lymphocytes (HP:0001922) | 2.05367180 |
| 118 | Abnormality of iron homeostasis (HP:0011031) | 2.04924738 |
| 119 | Alveolar cell carcinoma (HP:0006519) | 2.04222619 |
| 120 | Amyloidosis (HP:0011034) | 2.02768861 |
| 121 | Recurrent lower respiratory tract infections (HP:0002783) | 2.01834553 |
| 122 | Hypochromic anemia (HP:0001931) | 2.01292326 |
| 123 | Joint swelling (HP:0001386) | 1.99382229 |
| 124 | Mutism (HP:0002300) | 1.98701969 |
| 125 | Abnormality of the endocardium (HP:0004306) | 1.98536035 |
| 126 | Thrombophlebitis (HP:0004418) | 1.96998345 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.23968347 |
| 2 | TXK | 3.58145328 |
| 3 | MAP4K1 | 3.57175192 |
| 4 | KIT | 3.23342370 |
| 5 | TBK1 | 3.05695389 |
| 6 | JAK3 | 3.04311522 |
| 7 | IKBKB | 2.91123101 |
| 8 | IRAK4 | 2.89246596 |
| 9 | FLT3 | 2.81730649 |
| 10 | TYK2 | 2.80921407 |
| 11 | IKBKE | 2.57361254 |
| 12 | TEC | 2.31915168 |
| 13 | BTK | 2.20936370 |
| 14 | MAP3K13 | 2.20156853 |
| 15 | CSF1R | 2.19597812 |
| 16 | CHUK | 1.97804385 |
| 17 | GRK7 | 1.96826757 |
| 18 | PIM2 | 1.89593131 |
| 19 | ZAP70 | 1.85043333 |
| 20 | PRPF4B | 1.82746076 |
| 21 | SYK | 1.82302119 |
| 22 | BLK | 1.77174281 |
| 23 | JAK1 | 1.66972308 |
| 24 | RIPK4 | 1.52706650 |
| 25 | IRAK3 | 1.51068276 |
| 26 | TAOK2 | 1.46353435 |
| 27 | PIM1 | 1.38110221 |
| 28 | NME2 | 1.37892721 |
| 29 | MAP2K3 | 1.36678120 |
| 30 | TGFBR1 | 1.32898438 |
| 31 | MATK | 1.27116146 |
| 32 | LCK | 1.25272656 |
| 33 | FGR | 1.24090613 |
| 34 | TAOK3 | 1.19306305 |
| 35 | NLK | 1.18457798 |
| 36 | TGFBR2 | 1.14589722 |
| 37 | RPS6KA4 | 1.11117317 |
| 38 | LYN | 1.10185976 |
| 39 | EPHB1 | 1.07735152 |
| 40 | MARK3 | 1.03484490 |
| 41 | MAP3K1 | 1.02119805 |
| 42 | ITK | 0.98074023 |
| 43 | FES | 0.97907885 |
| 44 | HCK | 0.96959847 |
| 45 | MAP3K12 | 0.96355910 |
| 46 | MAP2K6 | 0.96152946 |
| 47 | IRAK2 | 0.92360199 |
| 48 | STK16 | 0.89376376 |
| 49 | JAK2 | 0.89091755 |
| 50 | EEF2K | 0.89050489 |
| 51 | ACVR1B | 0.88070224 |
| 52 | NEK9 | 0.82020768 |
| 53 | ADRBK2 | 0.81426996 |
| 54 | TNIK | 0.81367131 |
| 55 | KSR2 | 0.80045474 |
| 56 | FGFR4 | 0.78025152 |
| 57 | EPHA3 | 0.77608329 |
| 58 | MAP3K3 | 0.77211571 |
| 59 | TAOK1 | 0.76457384 |
| 60 | FGFR3 | 0.75838192 |
| 61 | PIK3CG | 0.75751614 |
| 62 | LRRK2 | 0.75125992 |
| 63 | MOS | 0.74805593 |
| 64 | KDR | 0.72406905 |
| 65 | CAMKK2 | 0.71593351 |
| 66 | EIF2AK2 | 0.70518065 |
| 67 | MUSK | 0.69444597 |
| 68 | MAPKAPK2 | 0.69257691 |
| 69 | STK4 | 0.68542111 |
| 70 | CSK | 0.67535524 |
| 71 | IRAK1 | 0.64463622 |
| 72 | TNK2 | 0.64223870 |
| 73 | BMPR2 | 0.63942705 |
| 74 | MAP3K5 | 0.63620632 |
| 75 | MAPKAPK5 | 0.62547430 |
| 76 | RPS6KA5 | 0.61146360 |
| 77 | GRK6 | 0.61052518 |
| 78 | STK10 | 0.60097502 |
| 79 | TYRO3 | 0.59424073 |
| 80 | CLK1 | 0.57514314 |
| 81 | CDC42BPA | 0.57404931 |
| 82 | SIK3 | 0.56623752 |
| 83 | DDR2 | 0.56203805 |
| 84 | VRK1 | 0.54611634 |
| 85 | PDK1 | 0.52678699 |
| 86 | MAP3K11 | 0.51386611 |
| 87 | MKNK1 | 0.50257627 |
| 88 | WEE1 | 0.49518432 |
| 89 | SCYL2 | 0.47057073 |
| 90 | RIPK1 | 0.46604721 |
| 91 | TRPM7 | 0.46489147 |
| 92 | PRKCD | 0.43355335 |
| 93 | PRKAA2 | 0.42806579 |
| 94 | TESK2 | 0.42478993 |
| 95 | ABL1 | 0.41403954 |
| 96 | MAP3K6 | 0.40544073 |
| 97 | ATR | 0.39314119 |
| 98 | STK24 | 0.39095040 |
| 99 | RPS6KB2 | 0.39054809 |
| 100 | RPS6KA6 | 0.38934691 |
| 101 | RAF1 | 0.38826647 |
| 102 | YES1 | 0.38373879 |
| 103 | MAPKAPK3 | 0.38349979 |
| 104 | CDK19 | 0.37557963 |
| 105 | PRKCQ | 0.37282811 |
| 106 | PRKG2 | 0.36418690 |
| 107 | DAPK2 | 0.36387242 |
| 108 | EIF2AK3 | 0.35870130 |
| 109 | ERN1 | 0.35484007 |
| 110 | DYRK3 | 0.35424925 |
| 111 | CDK4 | 0.34910694 |
| 112 | FYN | 0.34571867 |
| 113 | HIPK2 | 0.33753044 |
| 114 | KSR1 | 0.31329190 |
| 115 | NEK2 | 0.31278320 |
| 116 | MAPK4 | 0.31124236 |
| 117 | CDK6 | 0.31105253 |
| 118 | MAP3K2 | 0.31003085 |
| 119 | EGFR | 0.30376098 |
| 120 | MST4 | 0.30177661 |
| 121 | MAPK11 | 0.29249498 |
| 122 | NUAK1 | 0.26292829 |
| 123 | ALK | 0.25471873 |
| 124 | INSR | 0.24806949 |
| 125 | MAPK3 | 0.24641484 |
| 126 | BRSK2 | 0.24423564 |
| 127 | IGF1R | 0.24368964 |
| 128 | CCNB1 | 0.24245165 |
| 129 | RPS6KA1 | 0.23951028 |
| 130 | EIF2AK1 | 0.21718067 |
| 131 | PDK2 | 0.21030380 |
| 132 | PDPK1 | 0.20765667 |
| 133 | MAPK7 | 0.19261367 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 4.09587062 |
| 2 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.09009446 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.94476821 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.75721437 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.74699194 |
| 6 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.72117414 |
| 7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.55904148 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.54552738 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.54040127 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.42374314 |
| 11 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.32687453 |
| 12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.20394713 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.18667623 |
| 14 | Asthma_Homo sapiens_hsa05310 | 2.04964038 |
| 15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.97524839 |
| 16 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.91701129 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.91245454 |
| 18 | Legionellosis_Homo sapiens_hsa05134 | 1.85769195 |
| 19 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.83748921 |
| 20 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.79569835 |
| 21 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.71090810 |
| 22 | Ribosome_Homo sapiens_hsa03010 | 1.70645745 |
| 23 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.68725506 |
| 24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.66728957 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.65585317 |
| 26 | Pertussis_Homo sapiens_hsa05133 | 1.63389734 |
| 27 | DNA replication_Homo sapiens_hsa03030 | 1.60933398 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.59782027 |
| 29 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.53209331 |
| 30 | Shigellosis_Homo sapiens_hsa05131 | 1.44115729 |
| 31 | Malaria_Homo sapiens_hsa05144 | 1.42607923 |
| 32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.41649475 |
| 33 | Apoptosis_Homo sapiens_hsa04210 | 1.38634238 |
| 34 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.33523937 |
| 35 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.33280965 |
| 36 | Base excision repair_Homo sapiens_hsa03410 | 1.29697685 |
| 37 | Tuberculosis_Homo sapiens_hsa05152 | 1.28700672 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.26419383 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.22775280 |
| 40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.22190993 |
| 41 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.22134871 |
| 42 | Viral myocarditis_Homo sapiens_hsa05416 | 1.13423305 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.12988608 |
| 44 | Salmonella infection_Homo sapiens_hsa05132 | 1.10614891 |
| 45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.08392341 |
| 46 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.03709645 |
| 47 | Mismatch repair_Homo sapiens_hsa03430 | 1.03614405 |
| 48 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.01628562 |
| 49 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.99957610 |
| 50 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.99491251 |
| 51 | Proteasome_Homo sapiens_hsa03050 | 0.91321107 |
| 52 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.89722210 |
| 53 | Homologous recombination_Homo sapiens_hsa03440 | 0.88473595 |
| 54 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.86090766 |
| 55 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.83244584 |
| 56 | Platelet activation_Homo sapiens_hsa04611 | 0.79860658 |
| 57 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.76953608 |
| 58 | Hepatitis C_Homo sapiens_hsa05160 | 0.76070355 |
| 59 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.73421878 |
| 60 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.73038465 |
| 61 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.70847517 |
| 62 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.70634436 |
| 63 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.67313491 |
| 64 | Other glycan degradation_Homo sapiens_hsa00511 | 0.65203336 |
| 65 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.64754007 |
| 66 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.64606046 |
| 67 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.63795700 |
| 68 | Prion diseases_Homo sapiens_hsa05020 | 0.62487984 |
| 69 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62287637 |
| 70 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.60945945 |
| 71 | Spliceosome_Homo sapiens_hsa03040 | 0.58945695 |
| 72 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.58558104 |
| 73 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.55989026 |
| 74 | HTLV-I infection_Homo sapiens_hsa05166 | 0.55012840 |
| 75 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.53566261 |
| 76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51648997 |
| 77 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.48629919 |
| 78 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47797012 |
| 79 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.47495508 |
| 80 | RNA polymerase_Homo sapiens_hsa03020 | 0.45841957 |
| 81 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.43249934 |
| 82 | RNA degradation_Homo sapiens_hsa03018 | 0.42663885 |
| 83 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.42094581 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42006515 |
| 85 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.41994458 |
| 86 | Bladder cancer_Homo sapiens_hsa05219 | 0.40052325 |
| 87 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.39573347 |
| 88 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.37428392 |
| 89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.36129728 |
| 90 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.35667065 |
| 91 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.32421034 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30777789 |
| 93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.29588111 |
| 94 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.28755213 |
| 95 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.28474557 |
| 96 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.28280298 |
| 97 | Phagosome_Homo sapiens_hsa04145 | 0.24988012 |
| 98 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.24087173 |
| 99 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.23850512 |
| 100 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.23687968 |
| 101 | Cell cycle_Homo sapiens_hsa04110 | 0.22166727 |
| 102 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.22054146 |
| 103 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.21337420 |
| 104 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.20570256 |
| 105 | Insulin resistance_Homo sapiens_hsa04931 | 0.20143754 |
| 106 | Amoebiasis_Homo sapiens_hsa05146 | 0.19150709 |
| 107 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.19134979 |
| 108 | Lysosome_Homo sapiens_hsa04142 | 0.19116689 |
| 109 | Basal transcription factors_Homo sapiens_hsa03022 | 0.18480904 |
| 110 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.18456647 |
| 111 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.18283663 |
| 112 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.18194121 |
| 113 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.17450441 |
| 114 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.16957348 |
| 115 | Endocytosis_Homo sapiens_hsa04144 | 0.16102761 |
| 116 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.14982762 |
| 117 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.11236667 |
| 118 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.10809561 |
| 119 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.08469263 |
| 120 | Prostate cancer_Homo sapiens_hsa05215 | 0.07597380 |
| 121 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.07031633 |
| 122 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.05333145 |
| 123 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.03738836 |
| 124 | Mineral absorption_Homo sapiens_hsa04978 | 0.03521622 |
| 125 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.03145623 |

